Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: J Am Coll Cardiol. 2022 Oct 11;80(20):1925–1960. doi: 10.1016/j.jacc.2022.08.750

TABLE 2.

Clinical Decision Pathways With Hs-cTn

Approach Criteria for Rule Out Advantages Disadvantages
0/3 h Single hs-cTn <99th percentile URL if symptoms >6 h and now pain free
OR
If <6 h of symptoms, 0- and 3-h troponin less than the 99th percentile URL
  • Uses 99th percentile URL cutoffs similar to conventional troponin, which is familiar to clinicians

  • Conceptually simpler

  • Validated

  • Lower sensitivity and NPV, and fewer patients ruled out compared with other pathways

0-h (single draw) 0-h rule out for cTn below LoQ or an optimized cutoff (eg, hs-cTnI <5 ng/L)
  • Immediate rule out of low-risk patients

  • Takes advantage of sensitivity of hs-cTn

  • Applies to <50% of patients

  • Not suitable for patients presenting early

0/1-h rule out Use baseline (0-h) and delta values at 1 h to assign patients to the rule-out, observation, or abnormal groups
  • Takes advantage of better assay sensitivity and precision

  • Avoids inherent problems with 99th percentile URL value

  • Rules out a large proportion of patients

  • Complex algorithm

  • Timing of blood draws very important

  • May miss late-presenting MI on the “flat” portion of a declining troponin trend

0/2-h rule out Identical approach to 0/1-h rule out except delta assessed at 2 h
  • Takes advantage of higher sensitivity and precision of assay

  • More practical for some centers that cannot routinely obtain 1-h samples

  • Better for early presenters than 0/1-h algorithm

  • Longer time to rule out than 0/1-h algorithm

  • Equally complex as 0/1-h algorithm

  • May miss late-presenting MI on the “flat” portion of a declining troponin trend

  • Not validated in RCTs

High-STEACS MI is ruled out if initial hs-cTnI <5 ng/L or hs-cTnT <6 ng/L (if >3 h from symptom onset) or if change from initial to 3-h hs-cTn is <3 ng/L and remains below sex-specific 99th percentile URL
  • Takes advantage of better sensitivity and precision of assay

  • Safety and efficacy validated in randomized controlled trial61

  • High rates of safe rule out

  • Uses sex-specific 99th percentile cutpoint

  • Longer time to rule out for patients with initial hs-cTnI ≥5 ng/L or hs-cTnT ≥6 ng/L

  • Fewer patients discharged from ED than with 0/1- or 0/2-h algorithms

ED = emergency department; High-STEACS = High-Sensitivity Troponin in the Evaluation of Patients with Acute Coronary Syndrome; hs-cTn = high-sensitivity cardiac troponin; hs-cTnI = high-sensitivity cardiac troponin I; hs-cTnT = high-sensitivity cardiac troponin T; LoQ = limit of quantification; MI = myocardial infarction; NPV = negative predictive value; RCT = randomized controlled trial; URL = upper reference limit.